Sentences with phrase «immunology research programs»

Christophe Quéva, chief scientific officer, commented «The building of a custom designed R&D facility demonstrates our commitment to our cancer immunology research programs and will enable us to recruit additional qualified scientists needed in both our drug discovery and development.»

The Center for Cancer Immunology Research (CCIR) addresses immunology - based approaches to the treatment of cancer and has emerged as a one - of - a-kind cancer immunology research program that allows laboratory immunologists to work with clinical oncologists to develop new or improved forms of cancer immunotherapy that activate and instruct our immune system to eliminate cancer and prevent its recurrence.

From 1996 - 2003 he served as an Assistant Professor of Medicine in the Section of Oncology and as co-Director of the Immunology Research Program of the Yale Cancer Center.

Not exact matches

I spent the next decade completing rigorous basic science research training: completing a high school summer internship, attending the University of Maryland, Baltimore County as a Meyerhoff Scholar, and completing my Ph.D. in the Stanford immunology program, where my work focused on the mechanisms regulating hematopoietic and leukemic stem cells.

After receiving her Ph.D. in immunology from the Open University, United Kingdom, where she researched the identification of transcriptional factors regulating the unique phenotype of the human blood — brain barrier, she joined the Roche Brain Shuttle program as a postdoctoral fellow.

In his day job, at the University of Texas MD Anderson Cancer Center in Houston, Allison serves as chair of the immunology department, deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers and executive director of the immunotherapy division of the Moon Shots Program, a multidisciplinary effort tackling cancer mortality.

«Pancreatic cancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU Lprogram nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU LProgram at Perlmutter and vice chair for research in the Department of Surgery at NYU Langone.

The work was funded by the National Institutes of Health (CA42471, AI40127, AI84167, AI095634), the European Union (FP7 grant EC - FP7 - SYBILLA - 201106), the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research, the German Research Foundation (SFB 1054 TP A03), the Jane Coffins Childs Memorial Fund, the Pew Latin American Fellows Program in the Biomedical Sciences and the Finnish Doctoral Programme in Computational Sciences FICS.

After graduating I served as assistant coordinator of Meharry's Health Careers Opportunity Program before beginning my postdoctoral research fellow position in the department of pathology at HMS where I conducted basic cell biology and immunology research.

The sponsoring program for the research, NIH's Intramural NIAID Research Opportunities (INRO) Program, supports underrepresented minority students interested in pursuing a research career in allergy, immunology, or infectious diprogram for the research, NIH's Intramural NIAID Research Opportunities (INRO) Program, supports underrepresented minority students interested in pursuing a research career in allergy, immunology, or infectious dresearch, NIH's Intramural NIAID Research Opportunities (INRO) Program, supports underrepresented minority students interested in pursuing a research career in allergy, immunology, or infectious dResearch Opportunities (INRO) Program, supports underrepresented minority students interested in pursuing a research career in allergy, immunology, or infectious diProgram, supports underrepresented minority students interested in pursuing a research career in allergy, immunology, or infectious dresearch career in allergy, immunology, or infectious diseases.

«Our research shows that the protein GSK3 plays a crucial role in helping B cells meet the energy needs of their distinct states,» says Robert Rickert, Ph.D., director of the Tumor Microenvironment and Cancer Immunology Program at Sanford Burnham Prebys Medical Discovery Institute (SBP).

This new approach «represents an important advancement,» said Felicia Goodrum Sterling, the director of the graduate program in immunology at the University of Arizona Cancer Center, who was not involved in the research.

PHILADELPHIA --(July 11, 2017)-- Researchers at The Wistar Institute, an international leader in biomedical research in the fields of cancer, immunology and infectious diseases, with collaborators at Indiana University Melvin and Bren Simon Cancer Center and Syndax Pharmaceuticals, Inc., (Nasdaq: SNDX) announce the results of a preclinical study demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (MDSCs).

Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also serves as the chair of the Department of Gynecologic Oncology, the executive director of the Center for Immunotherapy, and the co-Leader of the Tumor Immunology and Immunotherapy research program.

In addition to Amgen's work to improve cancer patient treatment through science - based innovation, CRI will also recognize the company's commitment to the broader scientific and patient communities, both through its support of CRI's Cancer Immunotherapy Month education and awareness initiative, and for its support of the CRI - CIMT - EATI - AACR International Cancer Immunotherapy Conference, a joint program of four cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy research.

Cancer Research Institute inaugurates its Investigator Award Program for junior faculty members working in immunology and tumor immunology.

Dr. Levitsky: This is the first time that Roche has formally established a cancer immunology and immunotherapy research and development program within its structure.

Co-Leader, Host - Tumor Interactions Research Program Louise B. McGavock Professor of Pathology, Microbiology and Immunology Assistant Vice Chancellor for Integrative Diagnostics

Since 2000 Head of Lymphocyte Activation Unit Division of Immunology, Transplantation and Infectious Diseases Program in Immunology, Bio-Immuno-gene therapy of Cancer, IRCCS Ospedale San Raffaele, Milan, Italy 1998 - 1999 Research Associate Department of Molecular Biology and Functional Genomic, IRCCS Ospedale San Raffaele, Milan, Italy 1993 - 1998 Postdoctoral Associate Department of Microbiology University of Minnesota, Medical School Minneapolis, MN, USA 1991 - 1992 Department of Pharmacology, New York University, New York, USA 1989 - 1991 Department of Biomedical Science and Oncology, Turin, Italy 1988 - 1989 Research Fellow Department of Biomedical Science and Oncology, Turin, Italy 1989 - 1992 Ph.D. student in Molecular Oncology 1986 - 1988 Undergraduate student Department of Biomedical Science and Oncology, Turin, Italy

Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses in cancer and their potential therapeutic manipulation.

Other funding was from the Cancer Research Institute, the Academy of Finland Centre of Excellence in Molecular Systems, Immunology and Physiology Research program, the Damon Runyon Cancer Research Foundation (DRG -2069-11), and the National Science Foundation.

He founded the Immune Cell Biology Program and was head of the Department of Immunology at the Naval Medical Research Institute from 1990 to 1995.

Littman is the Helen L. and Martin S. Kimmel Professor of Molecular Immunology, a professor of pathology and microbiology, and a faculty member in the Molecular Pathogenesis program in the Skirball Institute for Biomedical Research at the New York University School of Medicine in New York, NY.

Within the fields of microbiology and immunology, neurologic diseases, neuropharmacology, behavioral, cognitive and developmental neuroscience, and psychiatric disorders, the center's research programs are seeking ways to: develop vaccines for infectious and noninfectious diseases; understand the basic neurobiology and genetics of social behavior and develop new treatment strategies for improving social functioning in social disorders such as autism; interpret brain activity through imaging; increase understanding of progressive illnesses such as Alzheimer's and Parkinson's diseases; unlock the secrets of memory; treat drug addiction; determine how the interaction between genetics and society shape who we are; and advance knowledge about the evolutionary links between biology and behavior.

Ira Brind Professor Professor and Co-Program Leader, Immunology, Microenvironment and Metastasis Program Member, The Wistar Institute Melanoma Research Center

In 2006, a team of Memorial Sloan Kettering investigators led by James P. Allison, former Chair of the Sloan Kettering Institute Immunology Program, was elected as one of six research groups across the country to share a $ 120 million gift from the Ludwig Fund, named after the late shipping industrialist Daniel K. Ludwig.

Dr. Lieping Chen currently serves as the United Technologies Corporation Professor in Cancer Research, Professor of Immunobiology, Dermatology and Medical Oncology at Yale School of Medicine and co-Director of the Cancer Immunology Program of Yale Cancer Center in New Haven, CT..

CRI Scientific Advisory Council director Lloyd J. Old, M.D., a pioneer responsible for many seminal discoveries in the field, is a senior expert in tumor immunology who for the past four decades has guided the scientific vision for CRI and who currently leads the Institute's global cancer vaccine research programs.

The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.

The feasibility of this program, both at the research and clinical levels, require multiple know - how (molecular biology, immunology, oncology, epidemiology, clinical diagnosis..)

Executive Vice President Director, Vaccine & Immunotherapy Center W.W. Smith Charitable Trust Professor in Cancer Research Professor, Immunology, Microenvironment & Metastasis Program

In 2016, Dmitry I. Gabrilovich, M.D., Ph.D., program leader of Wistar's Translational Tumor Immunology program, and his research team identified a marker for myeloid - derived suppressor cells (MDSCs), a population of immune cells implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy.

Jonathan Fogle, a veterinary internal medicine specialist and assistant professor of immunology in the North Carolina State University College of Veterinary Medicine, is one of 10 young scientists to receive a grant from the Creative and Novel Ideas in HIV Research program to investigate questions related to long - term survival with HIV infection, and the prevention of HIV transmission.

Immunology Research Department, National Hansen's Disease Programs, Laboratory Research Branch, Baton Rouge, LA 70803, USA.

Jonathan Fogle, a veterinary internal medicine specialist and assistant professor of immunology in the North Carolina State University College of Veterinary Medicine, is one of 10 young scientists to receive a grant from the Creative and Novel Ideas in HIV Research program to investigate questions related to long - term survival with HIV infection, and the prevention

Programs with research emphasis on epidemiology and public health, microbiology and immunology, clinical and anatomic pathology and laboratory animal medicine.

Berglund says the CVM's immunology research Ph.D. concentration within the comparative biomedical sciences program perfectly reflected her specific veterinary medicine interests.